Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ainhoa Lapitz

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Hepatology (Baltimore, Md.)|August 8, 2024
Comparative performance of methylation DNA markers, brushing cytology, and FISH in diagnosing malignant biliary stricturesJesus M Banales, Ainhoa Lapitz, Luca Fabris
Frontiers in Immunology|October 30, 2018
Extracellular Vesicles in Hepatobiliary MalignanciesAinhoa Lapitz, Ander Arbelaiz, Paula Olaizola, et al.
Cells|April 2, 2020
Extracellular Vesicles in NAFLD/ALD: From Pathobiology to TherapyAlejandra Hernández, Juan Pablo Arab, Daniela Reyes, et al.
Atherosclerosis|November 24, 2024
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)Santiago Iturbe-Rey, Claudia Maccali, Marco Arrese, et al.
International Journal of Molecular Sciences|January 25, 2025
Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel DiseasesMontse Baldán-Martín, Mikel Azkargorta, Ainhoa Lapitz, et al.
Frontiers in Microbiology|January 31, 2024
Identification of taxonomic changes in the fecal bacteriome associated with colorectal polyps and cancer: potential biomarkers for early diagnosisBeatriz Alessandra Rudi Grion, Paula Luize Camargos Fonseca, Rodrigo Bentes Kato, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 13, 2025
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- MiceCristina Di Giorgio, Ginevra Urbani, Silvia Marchianò, et al.
Hepatology (Baltimore, Md.)|February 10, 2026
Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytesEnara Markaide, Laura Izquierdo-Sanchez, Irene Olaizola, et al.
Cancers|June 4, 2020
A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal AdenocarcinomaRocio I R Macias, Luis Muñoz-Bellvís, Anabel Sánchez-Martín, et al.
Hepatology (Baltimore, Md.)|October 17, 2018
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing CholangitisJesus M Banales, Mercedes Iñarrairaegui, Ander Arbelaiz, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|August 8, 2024
Comparative performance of methylation DNA markers, brushing cytology, and FISH in diagnosing malignant biliary stricturesJesus M Banales, Ainhoa Lapitz, Luca Fabris
Frontiers in Immunology|October 30, 2018
Extracellular Vesicles in Hepatobiliary MalignanciesAinhoa Lapitz, Ander Arbelaiz, Paula Olaizola, et al.
Cells|April 2, 2020
Extracellular Vesicles in NAFLD/ALD: From Pathobiology to TherapyAlejandra Hernández, Juan Pablo Arab, Daniela Reyes, et al.
Atherosclerosis|November 24, 2024
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)Santiago Iturbe-Rey, Claudia Maccali, Marco Arrese, et al.
International Journal of Molecular Sciences|January 25, 2025
Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel DiseasesMontse Baldán-Martín, Mikel Azkargorta, Ainhoa Lapitz, et al.
Frontiers in Microbiology|January 31, 2024
Identification of taxonomic changes in the fecal bacteriome associated with colorectal polyps and cancer: potential biomarkers for early diagnosisBeatriz Alessandra Rudi Grion, Paula Luize Camargos Fonseca, Rodrigo Bentes Kato, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 13, 2025
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- MiceCristina Di Giorgio, Ginevra Urbani, Silvia Marchianò, et al.
Hepatology (Baltimore, Md.)|February 10, 2026
Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytesEnara Markaide, Laura Izquierdo-Sanchez, Irene Olaizola, et al.
Cancers|June 4, 2020
A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal AdenocarcinomaRocio I R Macias, Luis Muñoz-Bellvís, Anabel Sánchez-Martín, et al.
Hepatology (Baltimore, Md.)|October 17, 2018
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing CholangitisJesus M Banales, Mercedes Iñarrairaegui, Ander Arbelaiz, et al.
Pageof 2